Anzeige
Mehr »
Login
Mittwoch, 06.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
300% Aktienanstieg war nur der Vorgeschmack – Warum diese Kupferstory noch besser wird!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PQSS | ISIN: ES0105118006 | Ticker-Symbol: 4VP
Lang & Schwarz
06.11.24
07:34 Uhr
25,260 Euro
-25,260
-100,00 %
1-Jahres-Chart
QUADPACK INDUSTRIES SA Chart 1 Jahr
5-Tage-Chart
QUADPACK INDUSTRIES SA 5-Tage-Chart
RealtimeGeldBriefZeit
4,12046,40007:35
Actusnews Wire
633 Leser
Artikel bewerten:
(2)

QUADPACK: Combination of Quadpack Industries and PSB Industries at EUR 32 per share of Quadpack Industries

Quadpack Industries (Euronext Growth: ALQP) and PSB Industries (a private company), both manufacturers and providers of packaging solutions to the global beauty industry, are happy to announce their project to combine the two groups as further described below (the 'Transaction').

A strategic combination
After the operation is completed, the group will be positioned among the Top 5 cosmetics packaging companies worldwide, boasting combined sales of around €350 million, over 2,000 employees, an industrial presence in six countries and operational and commercial operations in Asia, Europe and the Americas.

The complementary nature of the two businesses, when combined, will enable an improved service to beauty brands, with an even more complete value proposition. Headquartered in Brion, France, Texen creates bespoke packaging solutions for the luxury makeup and perfumery markets from its factories in France, Poland, Mexico and the US. Headquartered in Barcelona, Spain, Quadpack provides standard packaging solutions for the masstige skincare and makeup markets. Its factories in Germany and Spain are complemented by an extensive sales network in Europe, the US and Australia.

Together, Texen and Quadpack will be able to reach new territories, new market segments and a broader client base, with a comprehensive, creative and sustainable product offer, from ready-to-use ranges to tailor-made solutions. The companies are already aligned in their commitment to sustainability and their ambition to lead the beauty packaging sector's eco-transition.

Structure
The structure of the Transaction will result in PSB Industries acquiring 100% of ALQP's share capital on one single closing date.

PSB Industries has committed to acquire a stake representing a total of 77.66% of ALQP's share capital (the 'Controlling Block') from the main shareholders of ALQP1 (the 'Founders').

The transfer of the Controlling Block will be carried out through:

  • A contribution in kind of 65.43% of ALQP's share capital in exchange for newly-issued PSB Industries shares. The exchange ratio will be based on a valuation of ALQP equal to €32 per share; and
  • An off-market sale in cash of 12.23% of ALQP's share capital at the same price.

Separately, PSB Industries has committed to acquire a stake of 9.85% of ALQP's share capital from a minority shareholder (the 'Minority Stake') at the same price (to be paid in cash) and on the same terms as the Founders.

The completion of the acquisition of the Controlling Block and the Minority Stake will be contingent upon the approval of an 'asymmetric' capital reduction by shareholders at ALQP's general shareholders' meeting held on the same date. All minority shareholders of ALQP will be able to sell their shares at the same price (€32 per share).

This capital reduction will involve the redemption of all ALQP shares not included in the Controlling Block and the Minority Stake, in accordance with Articles 293 and 329 of the Spanish Companies Law (the 'Capital Reduction').

The acquisition of the Controlling Block and the Minority Stake and the implementation of the Capital Reduction are inter-conditional and will take place simultaneously upon the approval of the Capital Reduction, in September/October 2024, so that PSB Industries will acquire 100% of ALQP's shares on such date, after the simultaneous closing of these transactions (all completed based on the same share price).

The Transaction will enable PSB Industries to hold 100% of ALQP's shares and to subsequently delist ALQP from the Euronext Growth market. The Founders will become shareholders of PSB Industries and therefore remain involved in the future development and growth of the new group.

Next steps
The Board of Directors of ALQP will appoint an independent expert to draft a report and to review the fairness of the offered price (ie, €32) for the purposes of the Capital Reduction.

The Transaction is not subject to regulatory approval.

The market will be kept informed of the progress of discussions between Quadpack and PSB Industries, and further announcements will be made in due course, as appropriate.

-ENDS-

1 Including Eudald Holdings, S.L., the majority shareholder of ALQP.

Press contacts
Mario Moratalla
Atrevia
m.moratalla@atrevia.com
+34 667 633 841

Patricia Cobo
Atrevia
pcobo@atrevia.com
+34 659 736 124

------------------------
This publication embed "Actusnews SECURITY MASTER".
- SECURITY MASTER Key: xW9uZ5WaY5mdnnFwkpZpZmJlaGdplWbKlpOWlWaaYpjKnG2RymuSbZSZZnFnnWdt
- Check this key: https://www.security-master-key.com.
------------------------
Full and original release in PDF format:
https://www.actusnews.com/documents_communiques/ACTUS-0-86827-combination-of-quadpack-industries-and-psb-industries-actus.pdf

© Copyright Actusnews Wire
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
© 2024 Actusnews Wire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.